Ovamex, Injektionslösung in einer Fertigspritze

7680687920018 CH-68792 Injektionslösung
Ovamex, Injektionslösung in einer Fertigspritze
Ovamex, Injektionslösung in einer Fertigspritze
Ovamex, Injektionslösung in einer Fertigspritze
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Fertigspritze(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
05/03/2024
Patient information leaflet
Français
05/03/2024
Patient information leaflet
Italien
05/03/2024
Summary of Product Characteristics
Allemand
05/03/2024
Summary of Product Characteristics
Français
05/03/2024
Summary of Product Characteristics
Italien
05/03/2024

Detailed composition

Substance Quantity Type Category
(N/A)
0.25 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.023 MG Substance HBESI

Authorization holder

Future Health Pharma GmbH

8620 Wetzikon ZH

Authorization information

Swissmedic authorization number
68792
Drug name
Ovamex, Injektionslösung in einer Fertigspritze
Galenic form
INLFS
ATC Code
H01CC01
Authorization status
Z
Dispensing category
A
First authorization
06/02/2023
Authorization expiration date
05/02/2028
IT Number
07.09.0.
Domain
Human medicine
Field of application
Assistierte Reproduktionsmedizin

Package details

Description (FR)
OVAMEX sol inj 0.25 mg/0.5ml ser pré
Description (DE)
OVAMEX Inj Lös 0.25 mg/0.5ml Fertspr
Market launch
06/02/2023
Narcotic (BTM)
No

Other package sizes (1)

None
5 FESP
GTIN: None
Not in V1